Virus reactivation in acute and long COVID-19
🚨Hidden viruses reactivate in nearly half of hospitalized COVID patients, tied to severity, inflammation & LongC0VID physical symptoms.
➡️Let’s revisit this very interesting and revealing study in which multi-omic longitudinal data from 1,154 unvaccinated hospitalized COVID-19 patients (IMPACC cohort, 2020–2021) were analysed, with a personal interpretation!
➡️Key findings:
- Significant reactivation of Herpesviridae (EBV, CMV, HSV1/2, HHV6) and Anelloviridae occurred in ~47.9% of patients during acute illness, with distinct temporal patterns (e.g, EBV earlier, CMV/HSV later),
- Reactivation correlated with greater disease severity, systemic inflammation (elevated cytokines such as IL-6, CXCL10), metabolomic shifts, immune changes, and poorer outcomes including mortality risk in critical cases,
- It frequently occurred in immunocompetent individuals, not primarily driven by immunosuppression or medications,
- Viral transcripts persisted into convalescence. Anelloviridae in PBMCs associated with physical deficits in LongC0VID, independent of age, severity, and immunosuppression,
- External validation supported the dynamics. No causation was claimed, but immune/transcriptomic/metabolomic signatures of reactivation were identified.
➡️The findings challenge the view that chronic virus reactivation is mainly an immunosuppression consequence and highlight its prevalence alongside inflammation in severe COVID-19.
➡️Interpretation:
‼️So, this intriguing study shows data that are consistent with a model in which:
1. SARSCoV2 directly drives immune dysregulation and inflammation, and
2. This “stress situation” reactivates other viruses that then secondarily MAGNIFY and/or PROLONG those same processes.
‼️This virus reactivation does not replace the direct SARSCOV2 effects, it adds a plausible secondary layer.
‼️These found signatures are at least partly independent of SARS-CoV-2 viral load and severity in some analyses, raising further the possibility that the secondary reactivated viruses actively contribute rather than being a pure side-effect/consequence of Covid-19.
‼️This hidden virus’s reactivation study further suggests that persistent Anelloviridae reactivation into convalescence may contribute to physical long-COVID deficits via ongoing inflammation and immune dysregulation, suggesting that monitoring or targeting such reactivations could help mitigate long-term sequelae( future for specific new antivirals?).
‼️Causality in either direction (or both) remains, as the authors state, a hypothesis and will need interventional and/or mechanistic follow-up studies.
‼️Nonetheless, this study is an important step forward in the exploration of SarsCoV2 and its broad and long-term (post-)infection impact!
#Bookmark
#AvoidSars2 #AvoidReinfection
nature.com/articles/s41586-0…